Prosensa Holding BV (RNA)

[oldberkeley]

The headline of this FierceBiotech article doesn't sugarcoat the situation and tells it like it is: GSK dumps a failed muscular dystrophy drug back in Prosensa's lap.

http://www.fiercebiotech.com/story/gsk-dumps-failed-muscular-dystrophy-drug-back-prosensas-lap/2014-01-13

The key word is dump, because that's what it is. GSK saw very little chance of approval. Prosensa absolutely did not terminate the agreement since it's the last thing they wanted.

I really can't see what Prosensa is going to do with drisapersen--try and find another partner I guess or even file again on its own with the FDA--but IMHO they'd be better off just to write it off and focus on the other stuff in their pipeline.

I'm hoping that there's a dead cat bounce to around $5 in the next few days and then I'm going to eat my big loss and move on.